CSCaroline Karlinski Scherer

Caroline Karlinski Scherer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caroline Karlinski Scherer has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Usability and clinical performance of a low-cost 3D-printed video laryngoscope: a mixed-methods evaluation

    by Ana Cristina Beitia Kraemer Moraes, Caroline Karlinski Scherer, Milena Souto Corrêa e Silva, Daniela Bialva Da Costa, Chiara Das Dores Do Nascimento, Everton Granemann Souza, Rafael Guerra Lund

    Introduction The 3D-printed video laryngoscope (VLP-3D) offers a low-cost alternative to commercial video laryngoscopes and could increase access to airway training and clinical resources, particularly in low-resource or educational settings. However, its usability and safety must be validated to ensure clinical readiness. Objective To evaluate the usability and procedural performance of a low-cost 3D-printed videolaryngoscope (VLP-3D) compared with a commercial videolaryngoscope using a mixed-methods approach in high-fidelity simulated airway scenarios. Method A mixed-method study was conducted with 60 physicians in high-fidelity simulated settings. Each participant evaluated both devices in a randomized within-subject design using a difficult-airway manikin. Usability was assessed using heuristic evaluation, structured testing and the System Usability Scale (SUS). Objective outcomes included laryngeal visualization time, total intubation time and intubation success. Exploratory random-effects meta-analyses integrated the current findings with comparative simulation studies. Data were analysed using Spearman’s rank correlation, logistic regression, Wilcoxon signed-rank tests and meta-analysis (RevMan V.5.4). Risk of bias was assessed according to Risk of Bias in Non-randomised Studies-of Interventions and Grading of Recommendations Assessment, Development and Evaluation. Results SUS scores were high for both devices (VLP-3D, 87.01; commercial, 85.09). In the paired analysis, no statistically significant differences were observed in laryngeal visualization time (mean difference [MD], VLP-3D minus commercial = 2.51 s; 95% CI −2.22 to 7.24; p=0.293) or total intubation time (MD=−0.88 s; 95% CI −8.19 to 6.43;p=0.811). The exploratory meta-analysis likewise showed no significant pooled difference in laryngeal visualization time (MD=−1.92 s; 95% CI −12.85 to 9.00; p=0.730; I²=83.1%) or total intubation time/time to successful intubation(MD=3.15 s; 95% CI −0.95 to 7.26; p=0.132; I²=56.1%). Heterogeneity reflected differences in device design,comparator type, study design, and outcome reporting across the available simulation studies. Conclusion The VLP-3D demonstrated high perceived usability and objective procedural performance comparable to the commercial standard in high-fidelity simulated airway scenarios. It demonstrates strong clinical and educational potential for training and selective use in airway management, bridging the gap between open-source affordability and rigorous medical device standards. Further standardized preclinical evaluation and prospective clinical studies are required before patient-level safety and effectiveness can be established.

  • Open Access

    O papel das citocinas na depressão resistente: Relações entre inflamação e resposta terapêutica - uma revisão sistemática

    by Larissa Silva Matiolli Martins, Julia Machado Simon de Carvalho, Camila Del Grande, Jackeline Delfini Ribeiro, Ibrahim Kanj Mohanna Filho, Caroline Karlinski Scherer, Matheus Akira Ishikiriyama, Giovanna Alves Benelli, Otávio Carvalho Colognhezi, Cecília Jacoby Rigol Silva, et al.

    A revisão sistemática destaca a neuroinflamação como um mecanismo central na Depressão Resistente ao Tratamento (DRT), não apenas um fenômeno secundário. A ativação de microglia e astrócitos por citocinas pró-inflamatórias (IL-6, TNF-α, IL-1β) compromete neurotransmissão, plasticidade sináptica e regulação do eixo HPA, contribuindo para a baixa resposta a ISRS e IRSN. A resistência terapêutica está associada à alteração dos sistemas serotonérgico e dopaminérgico, com desvio do triptofano para a via da quinurenina, redução de dopamina e aumento de metabolitos neurotóxicos, gerando excitotoxicidade e disfunção dos circuitos de recompensa. A diminuição de BDNF e da neuroplasticidade impede que antidepressivos convencionais promovam neurogênese e remodelagem sináptica, enquanto a desregulação do eixo HPA exacerba estresse oxidativo e disfunção mitocondrial. Assim, a DRT se mantém por um ciclo auto-sustentado de inflamação e falha da plasticidade neuronal, indicando a necessidade de terapias combinadas que incluam modulação inflamatória, neuroproteção e restauração dos sistemas de neurotransmi